Never Run Out of Charge With This Anker 737 140-Watt Power Bank, Now Down by 40%
Considering the number of devices we have today and their general lack of battery life, a portable power bank is becoming more essential by the day. That's why this Anker 737 power bank with 140-watt output is worth highlighting at $90. It's usually found for $150 but a 40% discount has taken it down to only $10 away from its lowest ever cost.
The Anker 737 Power Bank includes dual USB-C ports and a single USB-A port that will let you charge up to three devices at one go. And with support for 140-watt charging, even the most power-hungry laptops can be topped off on the go with ease. The Anker 737's large 24,000-mAh capacity means that it can comfortably top-up a laptop, or get you an additional four to five charges on an iPhone. That's impressive for a power bank that's barely the size of a soda can.
Hey, did you know? CNET Deals texts are free, easy and save you money.
Moreover, you won't need to guess the remaining charge using ambiguous LED lights. The Anker 737 includes a smart digital display that provides real-time information on charging speeds and recharge times. Designed for convenience, this power bank is TSA-approved and airline-safe, so you can easily carry it on your next flight.
Earning half the spots on our list of the best power banks of 2024, Anker is known for making some of the best mobile accessories on the market. This 737 didn't quite make the cut due to its higher price tag, but thanks to this steep 40% discount, it's a serious bargain and only $10 more than its lowest price ever, making it one of the best power banks you'll find in this price range.
Need a bigger backup? Why not check out the best power station deals on the market, such as Anker, EcoFlow, Bluetti and plenty more big-name brands?
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Capital Increase Reserved for Employees of TotalEnergies in 2025
PARIS, June 10, 2025--(BUSINESS WIRE)-- In accordance with its policy in favour of employee shareholding, the Board of Directors of TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) decided, on October 30, 2024, to carry out a capital increase reserved for eligible employees and former employees of TotalEnergies SE and its French and foreign subsidiaries in which the Company holds directly or indirectly more than 50% (in terms of capital or voting rights), that are members of the PEG-A Group savings plan, in France and abroad, under the conditions set by the twenty-second resolution at the Shareholders' Meeting of May 24, 2024. On April 29, 2025, the Chairman and CEO set (i) the subscription period from May 2 to May 15, 2025 (included) and (ii) the subscription price at 42.50 euros per share, corresponding to the average of the closing prices of the TotalEnergies share on Euronext over the twenty trading sessions preceding the date of this decision, reduced by a 20% discount and rounded off to the highest tenth of a euro. At the end of this period, 62,796 employees in 97 countries, representing 53% of the eligible employees and former employees, subscribed to this capital increase for an amount of 449.3 million euros. The 2025 results are close to those of 2024, a record year, and significantly higher than in previous years, both in terms of participation and amounts subscribed. "Employee share ownership is the best way to associate employees with the economic performance of the company, strengthen their sense of belonging and align the interests of employees and shareholders. Employees responded this year again massively to the capital increase reserved for them, and increasingly so, investing nearly 450 million euros, an amount close to last year's record of 480 million euros, and around 100 million more than the amounts of 2021, 2022, and 2023. These figures reflect an increase of 10,000 subscribers since 2024, when all employees received 100 shares to celebrate the 100th anniversary of the Company. It demonstrates that our employees have a strong and lasting confidence in their company and its strategy. This strong momentum has once again enabled TotalEnergies to confirm its position as the number one in employee shareholding in Europe in terms of capitalization held, and it was awarded with the 'Grand Prix' from the French Federation of Employee Shareholding", declared Patrick Pouyanné, Chairman and CEO of TotalEnergies. As a result, 11,149,053 new shares are being issued on June 10, 2025. They will carry immediate dividend rights and will be fully assimilated with TotalEnergies shares already listed on Euronext. Following this issuance, the employee shareholders in TotalEnergies SE's share capital, within the meaning of Article L. 225-102 of the French Commercial Code, is estimated at 8.8% of the Company's share capital as of June 10, 2025. About TotalEnergies TotalEnergies is a global integrated energy company that produces and markets energies: oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables and electricity. Our more than 100,000 employees are committed to provide as many people as possible with energy that is more reliable, more affordable and more sustainable. Active in about 120 countries, TotalEnergies places sustainability at the heart of its strategy, its projects and its operations. TotalEnergiesMedia Relations: +33 (0)1 47 44 46 99 l presse@ l @TotalEnergiesPR Investor Relations: +33 (0)1 47 44 46 46 l ir@ X @TotalEnergies LinkedIn TotalEnergies Facebook TotalEnergies Instagram TotalEnergies Cautionary Note The terms "TotalEnergies", "TotalEnergies company" or "Company" in this document are used to designate TotalEnergies SE and the consolidated entities that are directly or indirectly controlled by TotalEnergies SE. Likewise, the words "we", "us" and "our" may also be used to refer to these entities or to their employees. The entities in which TotalEnergies SE directly or indirectly owns a shareholding are separate legal entities. TotalEnergies SE has no liability for the acts or omissions of these entities. This document may contain forward-looking information and statements that are based on a number of economic data and assumptions made in a given economic, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither TotalEnergies SE nor any of its subsidiaries assumes any obligation to update publicly any forward-looking information or statement, objectives or trends contained in this document whether as a result of new information, future events or otherwise. Information concerning risk factors, that may affect TotalEnergies' financial results or activities is provided in the most recent Registration Document, the French-language version of which is filed by TotalEnergies SE with the French securities regulator Autorité des Marchés Financiers (AMF), and in the Form 20-F filed with the United States Securities and Exchange Commission (SEC). View source version on Contacts TotalEnergies Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hypebeast
44 minutes ago
- Hypebeast
The Biggest Announcements from Apple's WWDC25 Keynote
Today, at its WWDC25 keynote,Appleunveiled a slate of software updates across its entire product portfolio. From a revamped Phone app that merges calls and messages to a complete overhaul of its operating systems in both design and functionality, the changes mark its most comprehensive software refreshes to date. Apple even announced the Notes app is – finally – making its way toApple Watchand the phrase 'better late than never' has never felt more appropriate. But of all the updates Apple billed as 'groundbreaking' at WWDC25 today,Liquid Glassis arguably the biggest. A translucent new digital 'material',Liquid Glassunderpins Apple's refreshed visual language and arrives as part of its OS updates this fall. From app icons and menu bars to notification bubbles and beyond, it's being applied across the user interface (UI) of every Apple device, with its properties shaping the look and feel each element and how they interact with each other. And it's not just a reskin that adds new colors and a fresh aesthetic to the UI. According to Apple,Liquid Glassuses 'real-time rendering' and reacts dynamically to movement and user input – like real glass, it 'reflects and refracts its surroundings', responding to other onscreen elements nearby. Apple is hoping to create a more consistent and streamlined user experience (UX) across its devices and its latest visual updates usher in a new chapter in its design story. But these aren't the only changes it's making: Apple is also changing how it names its operating systems. Until now, Apple numbered its operating systems sequentially and categorized them by product – for example, the most recent operating systems foriPhoneandApple Watchare callediOS18 andwatchOS11, respectively. But going forward the brand is moving to a standardized naming system based on the year the software will serve. This fall, Apple will launch iOS 26, iPadOS 26, watchOS 26 – and so on. You get the idea. With iPhone and the upcoming iOS 26, users can expect to see a number of subtle updates across the device. The Phone app sees the biggest changes and will combine calls, messages and voicemails to create a unified space for users to view their various communications in one place. Apple is also introducing new privacy measures that automatically screen texts and calls from unknown numbers to help combat spam; in Messages, texts from these unknown numbers are placed in a separate folder – away from your main conversation list. The Phone app is also coming to Mac as part of Apple's drive for more synergy in its ecosystem. Taking advantage ofApple Intelligence, other updates on their way to iPhone include Live Translation, coming to Messages and FaceTime, which will provide real-time translations and live captions, respectively. Apple Maps is being improved and will be able to 'learn your routine and suggest alternative routes based on traffic', as well as taking note of places you've been to allow you to later look them up. The Wallet app is also seeing some changes with the introduction of Digital ID, a new feature Apple says is 'different from your driver's license and passport', but will be accepted for domestic travel at select airports. iPad– arguably the most under-leveraged device in Apple's lineup – is receiving a new windowing system that will let you resize and move app windows as you please, helping to improve the iPad's multitasking potential and allowing users to take more advantage of its untapped potential. iPad will also now have a menu bar that can auto-hide and pop out to gives users access to an app's most used features. With a new menu bar, users can access the commands available in an app with a simple swipe down from the top of the display, or by moving their cursor to the top. Users can quickly find a specific feature or related tips in an app by using search in the menu bar. Additionally, developers can now customise the menu bar in their own apps. Apple Watchusers are set to welcomeWorkout Buddy, a new motivational sports coach that lives on your wrist that will provide 'personal watchOS 26alised, spoken motivation with Apple Intelligence,' according to the brand. The Workout app is also being refreshed and will launch with a new layout in the fall in watchOS 26. AirPods, too, will see improvements, with Apple stating that users will soon be able to make 'studio-quality' audio recordings with them. AndApple CarPlayusers will soon see changes to how this looks insis car Apple'sCraig Federighi, senior vice president of Software Engineering, described today's updates as happening 'once every 10 years' – in fact, the last major overhaul on a similar level was with iOS 7 in 2013.
Yahoo
an hour ago
- Yahoo
ClavystBio and A*STAR Partner to Grow MedTech Ventures in Singapore
SINGAPORE, June 10, 2025 /PRNewswire/ -- ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to create and grow MedTech ventures in Singapore. This partnership will support venture creation, product development, and commercialisation by bringing together ClavystBio and two national initiatives hosted by A*STAR — MedTech Catapult and the Diagnostics Development Hub (DxD Hub) — along with A*STAR's broader MedTech and venture creation capabilities. The partnership comes amid growing momentum in Singapore's biomedical landscape, with MedTech output reaching S$20 billion in 2023.[1] As Asia's MedTech market is projected to grow to US$225 billion (S$304 billion) by 2030,[2] these efforts aim to better position Singapore-based innovations to scale and enter new markets. Over this two-year partnership, the parties will work towards the co-creation of new MedTech ventures, investments into A*STAR affiliated companies, and fostering collaborations between A*STAR and ClavystBio's portfolio companies. By combining complementary strengths — from research and engineering to venture building and funding — the partnership aims to identify promising technologies, shape MedTech projects for market readiness, and support new venture formation to strengthen Singapore's innovation-driven MedTech ecosystem. The partnership will focus on several key areas: Fostering new ventures from research: A*STAR and ClavystBio will jointly identify promising research and technologies to venture build new MedTech companies. A*STAR will contribute deep scientific expertise and structured venture creation support, while ClavystBio will provide access to venture and growth capital, expert guidance, and its extensive network to launch and scale these early-stage companies. Advancing MedTech product development: MedTech Catapult will support the development of medical devices through engineering design, prototyping, and manufacturing translation, while ClavystBio will draw on its investment and industry relationships to explore potential commercial pathways for promising innovations. Accelerating commercial readiness in diagnostics and digital health: DxD Hub and ClavystBio will shape ventures in this space with strong commercial potential. DxD Hub will bring technical and productisation expertise — including in AI-powered software, multi-omics, and point-of-care diagnostics — to refine innovations for commercial viability. ClavystBio will contribute its venture investing and venture building expertise to drive commercialisation. Strengthening Singapore's MedTech ecosystem: To support long-term sector growth, the partners will assess Singapore's MedTech manufacturing, design, and regulatory support landscape. MedTech Catapult will lead efforts to map ecosystem capabilities and identify gaps, while ClavystBio will explore investment opportunities in companies with specialised technologies that can strengthen Singapore's MedTech value chain. "This partnership highlights ClavystBio's commitment to nurturing globally successful medical devices, digital health, and diagnostics companies from Singapore," said Mr Anselm Tan, Digital Health & MedTech Lead at ClavystBio. "By combining ClavystBio's investment and venture-building expertise with A*STAR's deep scientific capabilities and productisation platforms, we are cultivating an ecosystem primed for innovation and commercial success. "A*STAR is committed to nurturing a dynamic MedTech ecosystem that bridges innovation with deep tech companies," said Ms Irene Cheong, Assistant Chief Executive (Innovation & Enterprise) at A*STAR. "This MoU builds on an existing collaboration with ClavystBio and marks a significant step forward in our joint efforts to co-create and grow globally investible MedTech ventures. Through national productisation platforms like MedTech Catapult and DxD Hub, combined with A*STAR's venture creation capabilities, we aim to commercialise more innovations from lab to market and grow a vibrant MedTech ecosystem in Singapore." [1] Speech by SMS Low Yen Ling at the MedTech Forum[2] Singapore's MedTech sector and locally made medical devices punching above their weight | Singapore EDB About ClavystBio ClavystBio is a life sciences investor and venture builder set up by Temasek to accelerate the commercialization of breakthrough ideas into health impact. We invest and partner with founders and entrepreneurs to launch and grow global companies from Singapore. Our focus spans therapeutics, digital health and medtech, with an emphasis on first-in-class science and technology. Our collaborative space, Node 1, provides plug-and-play spaces for ventures that have graduated from incubators to progress to their next milestones. By bringing start-ups together, we foster a vibrant and supportive community. About the Agency for Science, Technology and Research (A*STAR) The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector R&D agency. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit the economy and society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by improving societal outcomes in healthcare, urban living, and sustainability. A*STAR plays a key role in nurturing scientific talent and leaders for the wider research community and industry. A*STAR's R&D activities span biomedical sciences to physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis. For ongoing news, visit About Diagnostics Development Hub (DxD Hub) The Diagnostics Development Hub is a national platform hosted by the Agency for Science, Technology and Research (A*STAR). DxD Hub aims to accelerate the transformation of innovations into clinically validated diagnostic devices that are ready for market adoption. Through impactful products, empowering local enterprises and anchoring global companies in Singapore, DxD Hub contributes to the development of an effective diagnostic devices' ecosystem in Singapore. For ongoing news, visit About MedTech Catapult MedTech Catapult (MC) is a national initiative designed to accelerate the product development and commercialisation of high-value life science instruments and regulated medical devices. MC partners with product owners, local contract manufacturers (CMs), and leverages external design houses, and other key stakeholders to guide innovations from concept to market. Their goal is to strengthen Singapore's medtech ecosystem by providing dedicated engineering, quality assurance, regulatory affairs, clinical affairs, project management and commercialisation support to derisk and support products towards commercialisation and market adoption whilst supporting pull-through to local manufacturing. View original content to download multimedia: SOURCE ClavystBio Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
